Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy- N,N-dimethyltryptamine benzoate) in healthy participants
https://www.linkedin.com/feed/update/urn:li:activity:7200888698358431744
A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders
https://www.linkedin.com/feed/update/urn:li:activity:7184520052254085120
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations
https://www.linkedin.com/feed/update/urn:li:activity:7183377271368392704
